Sound Blade Medical, Inc., a Halifax, Nova Scotia, Canada-based medical device company developing handheld ultrasound-guided histotripsy technology, closed a US $16.5m Series A funding round.
Amzak Health and Lumira Ventures co-led the round, with participation from Invest Nova Scotia.
The company intends to use the funds to accelerate the development and clinical validation of its technology, expand the team and accelerate regulatory approvals to quickly bring its therapy to patients.
Founded in 2023, and led by Jeremy Brown, Ph.D., Co-founder and CEO, Sound Blade Medical is at the forefront of developing advanced handheld histotripsy technology with precision. Histotripsy is a non-invasive, non-ionizing and non-thermal ablation technology guided by real-time imaging that uses focused ultrasound delivered from outside the body to mechanically destroy targeted tissue. It works by inducing cavitation bubbles in the tissue at the ultrasound beam focus, using short, high-pressure pulses. When the bubbles collapse, only liquified tissue remains. Because of the non-thermal nature of the technology, it may allow better immune and healing responses and avoid dangers associated with heating.
FinSMEs
30/01/2025